Post-earnings recap
Reported
Thu, Feb 5, 2026
EPS actual
$1.31
EPS est.
$1.27
EPS surprise
+3.15%
1-day move
-1.41%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corporation reported an EPS of $1.31, beating expectations by 3.15%. However, the stock fell by 1.41% in reaction, indicating that investors may have been looking for more comprehensive revenue details or guidance, which were not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.31 | N/A | +3.15% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.